This is a randomized, placebo-controlled trial that will test the efficacy of VPNP in reducing HbA1c. Participant recruitment will occur through direct-to-participant enrollment. No additional clinical sites will be used for recruitment.
Protocol Amendment History
2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-12-14; most recent amendment 2025-01-27.